Table 2.
Treatment 1 | Fertilized Oocytes | Cleavage Rate (%) 2 | Blastocyst Rate (%) 3 |
---|---|---|---|
(1) Control | 224 | 84.04 ± 1.15 a | 34.76 ± 1.69 c |
(2) Negative control | 222 | 86.83 ± 1.15 a | 36.45 ± 1.69 bc |
(3) FF EVs SEC | 216 | 87.52 ± 1.15 a | 35.85 ± 1.69 bc |
(4) AOF EVs SEC | 221 | 87.85 ± 1.15 a | 39.79 ± 1.69 b |
(5) FF EVs + AOF EVs SEC | 212 | 84.93 ± 1.15 a | 37.27 ± 1.69 bc |
(6) FF EVs ODG UC | 218 | 86.72 ± 1.15 a | 45.41 ± 1.69 a |
(7) AOF EVs ODG UC | 220 | 88.34 ± 1.15 a | 48.74 ± 1.69 a |
(8) FF EVs+ AOF EVs ODG UC | 207 | 87.02 ± 1.15 a | 46.56 ± 1.69 a |
1 The treatments (eight groups) are defined in detail in the experimental design of the Materials and Methods and Figure 4. 2 The number of cleaved zygotes on day 2 out of the total number of fertilized oocytes (mean ± SE). 3 The number of blastocysts (day 8) out of the number of fertilized oocytes (mean ± SE). a, b, c Values in the same column with different superscripts differ significantly (p < 0.05). FF: follicular fluid. AOF: ampullary oviductal fluid.